Lifecare Yönetim

Yönetim kriter kontrolleri 2/4

Şu anda CEO hakkında yeterli bilgiye sahip değiliz.

Anahtar bilgiler

Joacim Holter

İcra Kurulu Başkanı

NOK 1.8m

Toplam tazminat

CEO maaş yüzdesi	100.0%
CEO görev süresi	4.1yrs
CEO sahipliği	0.1%
Yönetim ortalama görev süresi	Veri yok
Yönetim Kurulu ortalama görev süresi	3.9yrs

Son yönetim güncellemeleri

Recent updates

CEO Tazminat Analizi

Joacim Holter'un ücretlendirmesi Lifecare'un kazancına kıyasla nasıl değişti?
Tarih	Toplam Tazminat	Maaş	Şirket Kazançları
Jun 30 2024	n/a	n/a	-NOK 50m
Mar 31 2024	n/a	n/a	-NOK 42m
Dec 31 2023	NOK 2m	NOK 2m	-NOK 35m

Tazminat ve Piyasa: Joacim 'nin toplam tazminatı ($USD 170.88K ), German pazarındaki benzer büyüklükteki şirketler için ortalamanın altındadır ($USD 503.65K ).

Tazminat ve Kazançlar: Joacim şirketinin tazminatını şirket performansıyla karşılaştırmak için yeterli veri yok.

CEO

Joacim Holter

4.1yrs

Görev süresi

NOK 1,800,000

Tazminat

Mr. Joacim Holter serves as Head of Investor Relation at Lifecare AS. He has been the Chief Executive Officer at Lifecare AS since September 06, 2020 and had been a Director since 2011. He was the Chairman...

Yönetim Kurulu Üyeleri

İsim	Pozisyon	Görev süresi	Tazminat	Sahiplik
Bo Petersson	Independent Director	3.9yrs	NOK 180.00k	Veri yok
Hans Hekland	Independent Director	3.4yrs	NOK 180.00k	0.11% € 27.4k
Lutz Heinemann	Member of Scientific Advisory Board & Independent Director	3.9yrs	NOK 180.00k	Veri yok
David Klonoff	Chairman of Scientific Advisory Board	no data	Veri yok	Veri yok
Morten Krohnstad	Independent Chairman of the Board	3.9yrs	NOK 250.00k	Veri yok
Kåre Birkeland	Member of Scientific Advisory Board	no data	Veri yok	Veri yok
Michael Huth	Member of Scientific Advisory Board	4.8yrs	Veri yok	Veri yok
Trine Teigland	Independent Director	4.3yrs	NOK 180.00k	Veri yok
Tony James	Member of Scientific Advisory Board	less than a year	Veri yok	Veri yok

3.9yrs

Ortalama Görev Süresi

Deneyimli Yönetim Kurulu: LFC0 'nin yönetim kurulu üyeleri deneyimli olarak kabul edilir (ortalama görev süresi 3.9 yıldır).

Lifecare Yönetim

Yönetim kriter kontrolleri 2/4

Anahtar bilgiler

Son yönetim güncellemeleri

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

No independent directors

No independent directors

Recent updates

Lifecare ASA Announces Biopsies and Bacteriological Existing Implant

Lifecare AS has filed a Follow-on Equity Offering in the amount of NOK 20 million.

New major risk - Market cap size

Lifecare AS (OB:LIFE) commences an Equity Buyback Plan, under the authorization approved on September 17, 2024.

Lifecare AS Announces Successful Completion of the First Veterinary Patient of the Life Life Trial

New major risk - Revenue size

New major risk - Shareholder dilution

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 90 million.

Lifecare AS Files Application for a New Patent

Lifecare AS Announces Successful Pilot Production

Lifecare AS has filed a Follow-on Equity Offering in the amount of NOK 90 million.

Full year 2023 earnings released: kr0.29 loss per share (vs kr0.17 loss in FY 2022)

New major risk - Share price stability

Full year 2023 earnings released: kr0.27 loss per share (vs kr0.15 loss in FY 2022)

Lifecare AS Appoints Renete Kaarvik as Chief Financial Officer, Effective 1 Mai 2024

Lifecare AS Announces Appointment of Tony James to Its Scientific Advisory Board

Lifecare AS, Annual General Meeting, Apr 30, 2024

New minor risk - Shareholder dilution

Lifecare AS Announces the Norwegian Food Safety Authority Receives Approval to Start LFC-SEN-002

Lifecare AS has completed a Follow-on Equity Offering in the amount of NOK 42.5 million.

New major risk - Financial position

Lifecare AS to Report Q1, 2023 Results on May 10, 2023

No independent directors

Lifecare AS Announces Interim Data Analysis of the First In-Human Study

Lifecare as Initiates Clinical Studies of the Smallest Glucose Sensor in the Worldr People Diagnosed with Diabeabetes

No independent directors

Lifecare AS (OB:LIFE) signed a term sheet agreement to acquire PFÜTZNER Science & Health Institute GmbH for €1.18 million.

Lifecare AS (OB:LIFE) acquired Cantimed Ug (Haftungsbeschrsnkt) from NanoScale Systems Gmbh for €0.65 million.

Chairman of the Board Christian Hysing-Dahl has left the company

CEO Tazminat Analizi

CEO

Görev süresi

Tazminat

Yönetim Kurulu Üyeleri

Ortalama Görev Süresi